Similar articles

• In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera.

  Owens SE, Thatcher N, Sharma H, Adam N, Harrison R, Smith A, Zaki A, Baer JC, McAuliffe CA, Crowther D, et al. Owens SE, et al. Cancer Chemother Pharmacol. 1985;14(3):253-7. doi: 10.1007/BF00258128. Cancer Chemother Pharmacol. 1985. PMID: 3888431
• Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant disease.

  Thatcher N, Sharma H, Harrison R, Smith A, Zaki A, McAuliffe CA, Crowther D, Fox BW. Thatcher N, et al. Cancer Chemother Pharmacol. 1982;9(1):13-6. doi: 10.1007/BF00296754. Cancer Chemother Pharmacol. 1982. PMID: 6890414
• Pharmacokinetics and tissue distribution of liposome-encapsulated cis-bis-N-decyl-iminodiacetato-1,2-diaminocyclohexane-platinum (II).

  Lautersztain J, Perez-Soler R, Khokhar AR, Newman RA, Lopez-Berestein G. Lautersztain J, et al. Cancer Chemother Pharmacol. 1986;18(2):93-7. doi: 10.1007/BF00262274. Cancer Chemother Pharmacol. 1986. PMID: 3791565
• DNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II).

  Pendyala L, Arakali AV, Sansone P, Cowens JW, Creaven PJ. Pendyala L, et al. Cancer Chemother Pharmacol. 1990;27(3):248-50. doi: 10.1007/BF00685722. Cancer Chemother Pharmacol. 1990. PMID: 2265462
• [Platinum complexes as potential antineoplastic drugs].

  Kuduk-Jaworska J. Kuduk-Jaworska J. Postepy Hig Med Dosw. 1984 May-Jun;38(3):281-322. Postepy Hig Med Dosw. 1984. PMID: 6398870 Review. Polish. No abstract available.